BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it has successfully ...
A new study combines cfDNA fragmentomes and protein biomarkers to vastly improve early detection of ovarian cancer, offering a cost-effective and robust tool for mass screening. Study: Early detection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results